News

AI and biophysics unite to forecast high-risk viral variants before outbreaks
When the first reports of a new COVID-19 variant emerge, scientists worldwide scramble to answer a critical question: Will ...
Team finds flawed data in recent study relevant to coronavirus antiviral development
The COVID pandemic illustrated how urgently we need antiviral medications capable of treating coronavirus infections. To aid ...
Split RNA switch system boosts precision of cell-specific gene expression control
Professor Hirohide Saito (Department of Life Science Frontiers at CiRA / The University of Tokyo) and Assistant Professor ...
H.C. Wainwright Reaffirms Buy Rating on Sangamo After Promising Gene Therapy Data
Sangamo Therapeutics Inc. (NASDAQ:SGMO) ranks among the best CRISPR stocks to buy. Following the release of Sangamo ...
PharmiWeb3d
First Patient Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Haemophilia B in Germany
CSL Behring Germany today announced that the first haemophilia B patient in Germany was treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at the Hemophilia Treatment Center at ...
Key group of cerebral amygdala neurons identified in anxiety and social disorders
A research team has discovered that a specific group of neurons in the amygdala, a brain region involved in emotion ...
eLife4d
RNA: Searching for druggable targets
A strategy that analyzes the structural properties of RNA could help identify regions that are promising targets for antiviral drugs.
Science News6d
See how the herpesvirus reshapes our cells’ DNA in just eight hours
New imaging tools reveal how within an hour of infection, the virus begins to alter our chromosomes to kick-start its own replication.